Conjunctival low-grade non-Hodgkin's lymphoma: A large single-center study of initial characteristics, natural history and prognostic factors

Leukemia and Lymphoma

Volumn 47, Issue 7, 2006, Pages 1295-1305

  Meunier, Jérôme ^a   Rouïc, Livia Lumbroso Le ^a   Dendale, Rémi ^a   Vincent Salomon, Anne ^a   Asselain, Bernard ^a   Arnaud, Philippe ^a   Nëmati, Fariba ^a   Fourquet, Alain ^a   Desjardins, Laurence ^a   Plancher, Corine ^a   Levy, Christine ^a   Chaoui, Driss ^a   Validire, Patricia ^a   Decaudin, Didier ^a  

^a INSTITUT CURIE   (France)

Author keywords

Conjunctiva; Non Hodgkin's lymphoma

Indexed keywords

ALBUMIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BONE MARROW METASTASIS; CANCER GRADING; CANCER STAGING; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONJUNCTIVA TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EYE TOXICITY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM DISEASE; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SECOND CANCER; SKIN CARCINOMA; TREATMENT OUTCOME; XEROPHTHALMIA;

AGE FACTORS; CONJUNCTIVAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, LOW-GRADE; LYMPHOMA, NON-HODGKIN; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747662290     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500518966     Document Type: Article

References (40)

1. Feinstein, A and Krause, A. (1952) Ocular involvement in lymphomatous disease AMA Arch Ophthalmol, 48, pp. 328-337.
2. Fitzpatrick, P and Macko, S. (1984) Lymphoreticular tumors of the orbit Int J Radiat Oncol Biol Phys, 10, pp. 333-340.
3. Lambo, M and Brady, L and Shields, C.(1993) Lymphoid tumors of the orbit. In Radiotherapy of Intraocular and Orbital Tumors. (pp. 205-216). Berlin: Springer-Verlag.
4. Margo, C and Mulla, Z. (1998) Malignant tumors of the orbit. Analysis of the Florida Cancer Registry Ophthalmology, 105, pp. 185-190.
5. Harris, N and Jaffe, E and Diébold, J and Flandrin, G and Muller-Hermelink, H and Vardiman, J and (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997 J Clin Oncol, 17, pp. 3835-3849.
6. Oken, M and Creech, R and Tormey, D and Horton, J and Davis, T and McFadden, E and (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol, 5, pp. 649-655.
7. Carbone, P and Kaplan, H and Musshoff, K and Smithers, D and Tubiana, M. (1971) Report of the committee on Hodgkin's disease staging classification Cancer Res, 31, pp. 1860-1861.
8. Shipp, M and Harrington, D and Anderson, J and (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project N Engl J Med, 329, pp. 987-994.
9. Cheson, B and Horning, J and Coiffier, B and Shipp, M and Fisher, R and Connors, J and (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas J Clin Oncol, 17, pp. 1244-1253.
10. Kaplan, E and Meier, P. (1958) Nonparametric estimation from incomplete observations J Am Stat Assoc, 53, pp. 457-481.
11. Cox, D. (1972) Regression models and life tables J Roy Stat Soc, 34, pp. 187-220.
12. Knowles, D and Jakobiec, F and McNally, L and Burke, J. (1990) Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): A prospective multiparametric analysis of 108 cases during 1977 to 1987 Hum Pathol, 21, pp. 959-973.
13. Nakata, M and Matsumo, Y and Katsumata, N and Takenaka, T and Kobayashi, Y and Narabayashi, M and (1999) Histology according to the Revised European-American Lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma Leuk Lymphoma, 32, pp. 533-543.
14. Auw-Haedrich, C and Coupland, S and Kapp, A and Schmitt-Graff, A and Buchen, R and Witschel, H. (2001) Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification Br J Ophthalmol, 85, pp. 63-69.
15. Adachi, A and Tamaru, J and Kaneko, K and Kuroda, H and Miura, I and Kojima, T and (2004) No evidence of a correlation between BCL10 expression API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma Pathol Intern, 54, pp. 16-25.
16. Johnson, T and Tse, D and Byrne, G and Restrepo, A and Whitcomb, C and Voigt, W and (1999) Ocular-adnexal lymphoid tumors: A clinicopathologic and molecular genetic study of 77 patients Ophthal Plast Reconstr Surg, 15, pp. 171-179.
17. Shields, C and Shields, J and Carvalho, C and Rundle, P and Smith, A. (2001) Conjunctival lymphoid tumors: Clinical analysis of 117 cases and relationship to systemic lymphoma Ophthalmology, 108, pp. 979-984.
18. Bessell, E and Henk, J and Wright, J and Whitelocke, R. (1988) Orbital and conjunctival lymphoma treatment and prognosis Radiother Oncol, 13, pp. 237-244.
19. White, W and Ferry, J and Harris, N and Grove, A, Jr. (1995) Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type ;Ophthalmology, 102, pp. 1994-2006.
20. Esik, O and Ikeda, H and Mukai, K and Kaneko, A. (1996) A retrospective analysis of different modalities for treatment of primary orbital non-hodgkin's lymphomas Radiother Oncol, 38, pp. 13-18.
21. Restrepo, A and Raez, L and Byrne, G, Jr and Johnson, T and Ossi, P and Benedetto, P and (1998) Is central nervous system prophylaxis necessary in ocular adnexal lymphoma? Crit Rev Oncog, 9, pp. 269-273.
22. Bhatia, S and Paulino, A and Buatti, J and Mayr, N and Wen, B. (2002) Curative radiotherapy for primary orbital lymphoma Int J Radiat Oncol Biol Phys, 54, pp. 818-823.
23. Cho, E and Han, J and Ree, H and Ko, Y and Kang, Y and Ahn, H and (2003) Clinicopathologic analysis of ocular adnexal lymphomas: Extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients Am J Hematol, 73, pp. 87-96.
24. Fung, C and Tarbell, N and Lucarelli, M and Goldberg, S and Linggood, R and Harris, N and (2003) Ocular adnexal lymphoma: Clinical behavior of distinct WHO classification subtypes Int J Radiat Oncol Biol Phys, 57, pp. 1382-1391.
25. Jenkins, C and Rose, G and Bunce, C and Cree, I and Norton, A and Plowman, P and (2003) Clinical features associated with survival of patients with lymphoma of the ocular adnexa Eye, 17, pp. 809-820.
26. Martinet, S and Ozsahin, M and Belkacemi, Y and Landmann, C and Poortmans, P and Oehlere, C and (2003) Outcome and prognostic factors in orbital lymphoma: A rare cancer network study on 90 consecutive patients treated with radiotherapy Int J Radiat Oncol Biol Phys, 55, pp. 892-898.
27. Uno, T and Isobe, K and Shikama, N and Nishikawa, A and Oguchi, M and Ueno, N and (2003) Radiotherapy for extranodal, marginal-zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa Cancer, 98, pp. 865-871.
28. Coupland, S and Hellmich, M and Auw-Haedrich, C and Lee, W and Stein, H. (2004) Prognostic value of cell-cycle markers in ocular adnexal lymphoma: An assessment of 230 cases Graefes Arch Clin Exp Ophthalmol, 242, pp. 130-145.
29. Glass, A and Karnell, L and Menck, H. (1997) Data base report on non-Hodgkin's lymphoma Cancer, 80, pp. 2311-2320.
30. Thiéblemont, C and Berger, F and Dumontet, C and Moullet, I and Bouafia, F and Felman, P and (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed Blood, 95, pp. 802-806.
31. Tsang, R and Gospodarowicz, M and Pintilie, M and Wells, W and Hodgson, D and Sun, A and (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome J Clin Oncol, 21, pp. 4157-4164.
32. Zucca, E and Conconi, A and Pedrinis, E. (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue Blood, 101, pp. 2489-2495.
33. Jereb, B and Lee, H and Jakobiec, F and Kutcher, J. (1984) Radiation therapy of conjunctival and orbital lymphoid tumors Int J Radiat Oncol Biol Phys, 10, pp. 1013-1019.
34. Coupland, S and Krause, L and Delecluse, H and Anagnostopoulos, I and Foss, H and Hummel, M and (1998) Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases Ophthalmology, 105, pp. 1430-1441.
35. Bolek, T and Moyses, H and Marcus, R, Jr and Gorden, L, 3rd and Maiese, R and Almasri, N and (1999) Radiotherapy in the management of orbital lymphoma Int J Radiat Oncol Biol Phys, 44, pp. 31-36.
36. Jenkins, C and Rose, G and Bunce, C and (2000) Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival Br J Ophthalmol, 84, pp. 907-913.
37. Blasi, M and Gherlinzoni, F and Calvisi, G and Sasso, P and Tani, M and Cellini, M and (2001) Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: A preliminary report Ophthalmology, 108, pp. 559-552.
38. Nuckel, H and Meller, D and Steuhl, K and Duhrsen, U. (2004) Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva Eur J Haematol, 73, pp. 258-262.
39. Zinzani, P and Alinari, L and Stefoni, V and Loffredo, A and Pichierri, P and Polito, E. (2005) Rituximab in primary conjunctiva lymphoma Leuk Res, 29, pp. 107-108.
40. Matsuo, T and Yoshino, T. (2004) Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma Ophthalmology, 111, pp. 1233-1237.